Barry Merriman, Paul Mola

Nov 10, 2014

Human Longevity has hired Barry Merriman as vice president of global technology assessment and Paul Mola as head of global solutions. The two will work together in Human Longevity's new Global Solutions Initiative to seek business opportunities worldwide.

Merriman was previously lead system architect for advanced DNA sequencing at Life Technologies (now a division of Thermo Fisher Scientific). He was also formerly co-founder and CSO of Life Tech's Enterprise Genomics Solutions Group, and was on the faculty of the University of California, Los Angeles.

Mola also joins Human Longevity from Life Tech, where he was head of strategy and chief of staff for the genetic systems division and also a co-founder of the Enterprise Genomics Solutions Group. He also held product development roles at Applied Biosystems and Roche Diagnostics.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.